Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 3, 2003, Pages 543-553

  Marra, Alessandro ^a   Hillejan, Ludger ^a   Zaboura, George ^a   Fujimoto, Toshio ^a   Greschuchna, Dieter ^a   Stamatis, Georgios ^a  

^a RUHRLANDKLINIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH FLOW; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SURVIVAL RATE; TUMOR DIFFERENTIATION;

EID: 0037351608     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.322     Document Type: Article

References (31)

1. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet. 1998;352:257-63.
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-7.
3. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg. 1994;107:1398-402.
4. van Velzen E, Snijder RJ, Brutel de la Riviere A, Elbers HJ, van den Bosch JM. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. Chest. 1996;110:1469-73.
5. van Velzen E, Snijder RJ, Brutel de la Riviere A, Elbers HR, van den Bosch JM. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann Thorac Surg. 1997;63: 1436-40.
6. van Velzen E, de la Riviere AB, Elbers HJ, Lammers JW, van den Bosch JM. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. Ann Thorac Surg. 1999;67:903-7.
7. Asamura H, Suzuki K, Kondo H, Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer? Ann Thorac Surg. 2000;70:1839-46.
8. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-23.
9. Fujimoto T, Zaboura G, Fechner S, Hillejan L, Schröder T, Marra A, et al. Completion pneumonectomy: current indications, complications, and results. J Thorac Cardiovasc Surg. 2001;121:484-90.
10. World Health Organization. International histological classification of tumours. 2nd ed. Berlin: Springer-Verlag; 1988.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-70.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34: 187-220.
14. Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg. 1999;67:1572-6.
15. Yoshino I, Nakanishi R, Osaki T, Takenoyama M, Taga S, Hanagiri T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest. 1999;116:144-9.
16. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988;96:440-7.
17. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg. 1992;54:460-6.
18. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70:358-66.
19. Maggi G, Casadio C, Mancuso M, Oliaro A, Cianci R, Ruffini E. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. Int Surg. 1990;75:17-21.
20. Ferguson MK, Little AG, Golomb HM, Hoffman PC, DeMeester TR, Beveridge R, et al. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986;91:344-9.
21. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Lange CM, et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. Ann Thorac Surg. 1999;68:1171-6.
22. Marks LB, Prosnitz LR. Postoperative radiotherapy for lung cancer: the breast cancer story all over again? Int J Radiat Oncol Biol Phys. 2000;48:625-7.
23. Wagner H. Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years. Chest. 2000;117:110S-8S.
24. Bunn PA, Mault J, Kelly K. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer. A time for reassessment? Chest. 2000;117:119S-22S.
25. Strauss GM. Role of chemotherapy in stages I to III non-small cell lung cancer. Chest. 1999;116:509S-16S.
26. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ. 1995;311: 899-909.
27. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153-8.
28. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 1994;86:673-80.
29. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrik A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non- small cell lung cancer: mature results of a phase II trial. J Clin Oncol. 1998;16:622-34.
30. Stamatis G, Eberhardt W, Stuben G, Bildat S, Dahler O, Hillejan L. Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann Thorac Surg. 1999;68:1144-9.
31. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB, Kris MG, Johnson DH, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg. 2000;119:429-39.